During orthodontic tooth movement, local hypoxia and enhanced osteoclastogenesis are observed in the compression side of periodontal tissues. The receptor activator of nuclear factor-κB ligand (RANKL) is an osteoblast/ stromal cell-derived factor that is essential for osteoclastogenesis. In this study, we examined the effect of hypoxia on RANKL expression in human periodontal ligament fibroblasts (PDLFs) to investigate the relationship between local hypoxia and enhanced osteoclastogenesis in the compression side of periodontal tissues. Hypoxia significantly enhanced the levels of RANKL mRNA and protein as well as hypoxia inducible factor-1α (HIF-1α) protein in PDLFs. Constitutively active HIF-1α alone significantly increased the levels of RANKL expression in PDLFs under normoxic conditions, whereas dominant negative HIF-1α blocked hypoxia-induced RANKL expression. To investigate further whether HIF-1α directly regulates RANKL transcription, a luciferase reporter assay was performed using the reporter vector containing the RANKL promoter sequence. Exposure to hypoxia or overexpression of constitutively active HIF-1α significantly increased RANKL promoter activity, whereas dominant negative HIF-1α blocked hypoxia-induced RANKL promoter activity. Furthermore, mutations of putative HIF-1α binding elements in RANKL promoter prevented hypoxia-induced RANKL promoter activity. The results of chromatin immunoprecipitation showed that hypoxia or constitutively active HIF-1α increased the DNA binding of HIF-1α to RANKL promoter. These results suggest that HIF-1α mediates hypoxia-induced up-regulation of RANKL expression and that in compression side periodontal ligament, hypoxia enhances osteoclastogenesis, at least in part, via an increased RANKL expression in PDLFs.
INTRODUCTION
The periodontal ligament (PDL) is a highly collagenous structure that serves a supportive function by attaching the tooth to the surrounding alveolar bone and a shock-absorbing function by providing resistance to mechanical force (Shuttleworth and Smalley, 1983) . Mechanical force-induced orthodontic tooth movement is characterized by remodeling changes in the PDL and alveolar bone. Orthodontic tooth movement exerts different effects on two opposing sides, the compression and tension sides. Bone resorption is dominant on the compression side, whereas bone formation is dominant on the tension side (Cattaneo et al., 2005) . Compressive force reduces blood flow in the PDL and alveolar bone, which leads to local hypoxia (Kitase et al., 2009; Kubota, 1989) . Orthodontic tooth movement causes compression side PDLs to release various inflammatory mediators such as interleukin-1 (IL-1), tumor necrosis factor-α, IL-6 and prostaglandin E 2 (Kanzaki et al., 2002) . These molecules can cause various cellular responses in and around moving teeth, providing a favorable microenvironment for bone resorption and tooth movement. Although these inflammatory mediators are known to stimulate osteoclastogenesis, the underlying mechanisms regulating osteoclastogenesis in compression side PDL tissues have not been fully elucidated. Receptor activator of nuclear factor-κB ligand (RANKL) is an essential factor for osteoclastogenesis that is produced by osteoblasts and bone marrow stromal cells (Wada et al., 2006) . RANKL induces osteoclast differentiation from hematopoietic precursors and stimulates the bone-resorbing activity of osteoclasts (Suda et al., 1999; Udagawa et al., 1999) . It has been reported that continuous compression up-regulates RANKL expression in rat PDL in vivo (Ogasawara et al., 2004) . Compressive force significantly increases the expression of RANKL but decreases osteoprotegerin, a decoy receptor for RANKL, in human PDL fibroblasts (PDLFs) cultured in vitro in a time-and magnitude-dependent manner (Nishijima et al., 2006) . It has also been demonstrated that intermittent force up-regulates RANKL expression via IL-1 in human PDLFs (Nakao et al., 2007) . The results from these studies suggest that enhanced osteoclastogenesis in compression side PDLs may be partly caused by compressive force-induced RANKL expression in PDLFs. However, the regulatory role of local hypoxia per se in RANKL expression in compression side PDLs remains unclear.
Hypoxia activates hypoxia inducible factor 1 (HIF-1), a heterodimeric transcription factor comprised of α (inducible) and β (ubiquitous) subunits (Loboda et al., 2010) . Under hypoxic conditions, HIF-1α is stabilized and translocated to the nucleus. In the nucleus, HIF-1α binds to its dimerization partner, HIF-1β, and stimulates the expression of its target genes, such as vascular endothelial growth factor (VEGF). Hypoxia stimulates bone resorption by promoting both the osteoclastic differentiation of hematopoietic precursor cells and the bone-resorbing activity of osteoclasts (Arnett et al., 2003; Knowles and Athanasou, 2009 ). In addition to direct regulation of osteoclast precursor cells, hypoxia enhances osteoclast differentiation indirectly by increasing the secretion of VEGF and insulin-like growth factor 2 from osteoblasts and non-osteoclastic bone marrow cells, respectively (Fukuoka et al., 2005; Knowles and Athanasou, 2008) . However, the regulatory role of hypoxia in RANKL expression remains unknown.
In the present study, we investigated whether hypoxia regulates RANKL expression in human PDLFs. Here we show that hypoxia induces RANKL expression in human PDLFs and that HIF-1α mediates hypoxia-induced RANKL expression by directly binding the RANKL promoter.
MATERIALS AND METHODS

Materials
Alpha-modified Eagle's medium (α-MEM), fetal bovine serum (FBS) and other cultural reagents were obtained from Hyclone (USA). A GasPak™ EZ CO 2 Pouch System was purchased from BD (USA). The easy-BLUE™ and i-StarTaq™ reagents and WEST-ZOL (plus) were purchased from iNtRON Biotechnology (Korea). The AccuPower RT-PreMix was from Bioneer (Korea), and the SYBR Premix Ex Taq™ was from TaKaRa (Japan). The PCR primers were synthesized by CosmoGenetech (Korea). Anti-HIF-1α antibody was purchased from NOVUS (USA), anti-RANKL antibody was from R&D Systems (USA), anti-actin antibody was from Santa Cruz Biotechnology (USA) and HRP-conjugated secondary antibodies were from Thermo Fisher Scientific (USA). LipofectAMINE 2000 reagent was purchased from Invitrogen (USA). The human RANKL ELISA kit pink-ONE was obtained from Koma Biotech (Korea). The Dual-Glo™ luciferase assay system was ordered from Promega (USA).
Cell culture and hypoxic treatment
Human PDLFs (ScienCell™ Research Laboratories, USA) were maintained in α-MEM supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. To induce hypoxia, the PDLFs were transferred to a GasPak pouch, where the total oxygen concentration was reduced to less than 1% (Steinbach et al., 2004) , and incubated for the periods indicated. To induce HIF-1α, the PDLFs were incubated for 24 h in the presence of desferoxamine (DFO, 200 μM), a high affinity iron chelator (Hamrick et al., 2005) . PDLFs were used between passages four to six for the experiments.
Reverse transcription-polymerase chain reaction (RT-PCR) analysis
Semi-quantitative RT-PCR or quantitative real-time PCR was performed to evaluate mRNA expression. Total RNA was isolated using easy-BLUE™ RNA Extraction Reagents. Complementary DNA was synthesized from 1 μg of total RNA using the AccuPower RT-PreMix and was subsequently used for PCR amplification. Semi-quantitative RT-PCR was performed using i-StarTaq™ in the range of linear amplification. The PCR products were separated on a 1.2% agarose gel and visualized by ethidium bromide staining. The primer sequences used for the RT-PCR were as follows: RANKL-forward (f) 5′-AGAGCG CAGATGGATCCTAA-3′, RANKL-reverse (r) 5′-TTCCTTTTGC ACAGCTCCTT-3′; and GAPDH-f 5′-TGAAGGTCGGAGTCAA CGGATTTGGT-3′, GAPDH-r 5′-CATGTGGGCCATGAGGTCC ACCAC-3′. Real-time PCR was performed using the SYBR Premix Ex Taq™ and an AB 7500 Fast Real-Time system (Applied Biosystems, USA). Each sample was analyzed in triplicate, and target genes were normalized to GAPDH. Fold differences were then calculated for each treatment group using normalized C T values for the control. The primer sequences used for the real-time PCR were as follows: RANKL-f 5′-AGAGCGCA GATGGATCCTAA-3′, RANKL-r 5′-TTCCTTTTGCACAGCTCC TT-3′; VEGF-f 5′-GCTGTCTTGGG TGCATTGGA-3′, VEGF-r 5′-ATGATTCTGCCCTCCTCCTTC T-3′; and GAPDH-f 5′-CCATCTTCCAGGAGCGAGATC-3′, GAPDH-r 5′-GCCTTCT CCATGGTGGTGAA-3′.
Plasmid constructs and site-directed mutagenesis
The constitutively active and dominant negative HIF-1α expression plasmids were generous gifts from Prof. J.-W. Park at Seoul National University (Chun et al., 2002) . The reporter construct containing the mouse RANKL promoter (RANKL-luc) was prepared as follows: the DNA sequence spanning -2174 to +1 bp was amplified by PCR using the following primers: f 5′-CGAGCTCAGAATGAGGTGGTGGTCTTGCAGAC-3′ and r 5′-CCAAGCTTGGCGCGGCGCCCGGAGTTCG-3′. The amplicons were ligated into the SacI and HindIII sites of pGL3-Basic to generate RANKL-luc. To produce the function-defective reporter construct (RANKL-MT-luc), which contains mutations in the putative HIF-1α binding site, a site-directed mutagenic PCR was performed at -971 to -968 and -965 to -962 bp (CGTG->AAAA) (Amarilio et al., 2007) . The PCR primers used for the site-directed mutagenesis were as follows: f 5′-TGTGCGCG CGCGAAAATGAAAACTTGCGCACATGCCGGAGGA-3′ and r 5′-TCCTCCGGCATGTGCGCAAGTTTTCATTTTCGCGCGCG CACA-3′. PCR products were then used to replace the wildtype counterpart of the reporter vector.
Western blot analysis
For RANKL detection, PDLFs were scraped into lysis buffer (10 mM Tris-Cl [pH 7.5], 150 mM NaCl, 1 mM EDTA [pH 8.0], 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM sodium fluoride, 0.2 mM sodium orthovanadate, 1 mM PMSF, 1 μg/ml aprotinin, 1 μM leupeptin and 1 μM pepstatin) and sonicated briefly. Protein concentrations were determined using a modified Bradford method. The proteins were separated using a 10% SDS-PAGE gel and then electro-transferred onto a PVDF membrane. For HIF-1α detection, confluent cells were lysed in 2× Laemmli sample buffer, and the proteins were separated using a 6% SDS-PAGE gel. The membrane was blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20 and incubated with the relevant primary antibody, followed by incubation with the corresponding HRP-conjugated secondary antibody. Immune complexes were visualized using WEST-ZOL (plus) reagent and luminescence was detected with a LAS1000 (Fuji PhotoFilm; Japan).
